Clinical Trial Update: Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI [NA]

View source ↗

Summary

Clinical trial update on a study evaluating the RenalGuard system to protect patients at high risk of acute kidney injury, sponsored by the European Cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Kidney Injury

Drugs mentioned

• RenalGuard

Snippet

Sponsor: European Cardiovascular Research Center | Conditions: Cardiovascular Disease, Acute Kidney Injury | NA | Status: UNKNOWN